PLUS THERAPEUTICS, INC. — Director's Dealing 2022

Jun 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2022-06-02

Reporting Person: Clowes Howard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-02	Common Stock	P	15000	$0.5726	Acquired	18000	Direct